| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/PGS-2016-0099 |
| P8608 | Fatcat ID | release_2nmara5ngjhflba3crjguepam4 |
| P698 | PubMed publication ID | 27790940 |
| P50 | author | Adrián Llerena | Q56419301 |
| Guadalupe Ortíz-López | Q73435106 | ||
| Katy Sanchez-Pozos | Q88474477 | ||
| P2093 | author name string | Barbara Itzel Peña-Espinoza | |
| María de Los Ángeles Granados-Silvestre | |||
| María Helena García-Rodríguez | |||
| Marta Menjívar | |||
| Carolina Rivera-Santiago | |||
| P2860 | cites work | A simple salting out procedure for extracting DNA from human nucleated cells | Q27861086 |
| Admixture and population structure in Mexican-Mestizos based on paternal lineages | Q28271791 | ||
| Fast model-based estimation of ancestry in unrelated individuals | Q29614705 | ||
| Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms | Q33813015 | ||
| Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions | Q33867239 | ||
| Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. | Q34041231 | ||
| Reconstructing the history of Mesoamerican populations through the study of the mitochondrial DNA control region | Q34427232 | ||
| Pharmacogenetics of drug-metabolizing enzymes in US Hispanics | Q35661209 | ||
| Pharmacogenomic assessment of Mexican and Peruvian populations | Q35890226 | ||
| Reconstructing the population genetic history of the Caribbean. | Q37308682 | ||
| Introduction to personalized medicine in diabetes mellitus | Q37523745 | ||
| Polymorphisms of human cytochrome P450 2C9 and the functional relevance | Q37588810 | ||
| Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation | Q38075335 | ||
| Cytochrome P450 genetic polymorphisms of Mexican indigenous populations. | Q38154408 | ||
| Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes. | Q38643436 | ||
| Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers | Q38664576 | ||
| Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics | Q39232150 | ||
| Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements. | Q39862947 | ||
| Y-chromosome diversity in Native Mexicans reveals continental transition of genetic structure in the Americas | Q44303995 | ||
| CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards. | Q46221248 | ||
| Influence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico. | Q46298744 | ||
| Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards. | Q46975102 | ||
| Allele frequency distribution of CYP2C9 2 and CYP2C9 3 polymorphisms in six Mexican populations. | Q51067404 | ||
| Importance of the geographic barriers to promote gene drift and avoid pre- and post-Columbian gene flow in Mexican native groups: Evidence from forensic STR Loci. | Q53770031 | ||
| Diabetes susceptibility in Mayas: Evidence for the involvement of polymorphisms in HHEX, HNF4α, KCNJ11, PPARγ, CDKN2A/2B, SLC30A8, CDC123/CAMK1D, TCF7L2, ABCA1 and SLC16A11 genes. | Q55062145 | ||
| P433 | issue | 17 | |
| P304 | page(s) | 1881-1889 | |
| P577 | publication date | 2016-10-28 | |
| P1433 | published in | Pharmacogenomics | Q15724625 |
| P1476 | title | Genetic variability of CYP2C9*2 and CYP2C9*3 in seven indigenous groups from Mexico | |
| P478 | volume | 17 |
Search more.